Table 1.
Original model |
Reduced model |
|||
---|---|---|---|---|
№ | Reactions (Kinetics) | Rates (nM/min) | № | Reactions (Kinetics) |
Activation of caspase-8 induced by CD95 | ||||
br1 |
CD95L + CD95R → СD95R:СD95L (MA) |
101/100 |
br1* |
CD95L → DISC (kLR · CCD95R · CCD95L, CCD95R is determined by the formula (14)) |
br2 |
FADD + СD95R:СD95L → DISC (MA) |
101/100 |
|
|
br3 |
pro8 + DISC → DISC:pro8 (MA) |
100/10-1 |
|
|
br4 |
pro8 + DISC:pro8 → DISC:pro82 (MA) |
100/10-1 |
|
|
br5 |
DISC:pro82 → DISC:p43/p41 (MA) |
100/10-1 |
br2* |
pro8 –DISC → casp8 (kDISC_pro8 · Cpro8 · CDISC) |
br6 |
DISC:p43/p41 → casp8 + DISC (MA) |
100/10-1 |
|
|
Activation of caspase-8 by caspase-3 | ||||
br7 |
pro6 -casp3 → casp6 (M-M) |
100/10-1 |
br3* |
pro8 –casp3 → casp8 (k38 · Ccasp3) |
br8 |
pro8 -casp6 → casp8 (M-M) |
10-1/100 |
|
|
Inhibition of the DISC complex | ||||
br9 |
DISC + cFLIPL → DISC:cFLIPL (MA) |
101/100 |
br4* |
cFLIP + 2·DISC + pro8 → DISC:FLIP:pro8 (kDISC_FLIP · CFLIP · CDISC) |
br10 |
pro8 + DISC:cFLIPL → DISC:cFLIPL:pro8 (MA) |
100 |
|
|
br11 |
DISC + cFLIPS → blocked DISC (MA) |
101/100 |
|
|
br12 |
DISC:pro8 + cFLIPL → DISC:cFLIPL:pro8 (MA) |
10-2/10-3 |
br5* |
DISC:FLIP:pro8 → p43/p41 (kDFp8 · CDISC:FLIP:pro8) |
br13 |
DISC:pro8 + cFLIPS → blocked DISC (MA) |
10-2/10-3 |
|
|
br14 |
DISC:cFLIPL:pro8 → p43/p41 + blocked DISC (MA) |
10-1 |
|
|
Activation of caspase-9 triggered by cytochrome C | ||||
br15 |
Cyt C stored → Cyt C (frelease(t)·CCytCstored) |
102 |
br6* |
pro9 → cleavage (the formula (16)) |
br16 |
Apaf-1 + Cyt C → Cyt C:Apaf-1 (MA) |
102 |
|
|
br17 |
Cyt C:Apaf-1 → Apaf-1 + Cyt C (MA) |
101 |
|
|
br18 |
pro9 + Cyt C:Apaf → Apop (MA) |
100 |
|
|
br19 |
Apop -casp3 → casp9 + Cyt C:Apaf-1 |
100 |
|
|
|
(M-M) |
|
|
|
br20 |
Apop → casp9 + Cyt C:Apaf-1 (MA) |
10-2 |
|
|
Activation of Bid | ||||
br21 |
pro2 –casp3 → casp2 (M-M) |
100 |
br7* |
Bid –casp8 → tBid () |
br22 |
Bid –casp8 → tBid (M-M) |
100 |
|
|
br23 |
Bid –casp2 → tBid (M-M) |
10-1/100 |
br8* |
pro2 –casp3 → cleavage () |
Blocking of IAP by Smac | ||||
br24 |
Smac stored → Smac (frelease(t)·CSmac stored) |
102 |
– |
|
br25 |
Smac + IAP → IAP:Smac (MA) |
10-5 |
|
|
br26 |
IAP:Smac → Smac + IAP (MA) |
10-5 |
|
|
Activation of caspases-3 and −7 | ||||
br27 |
pro3 –casp8 → casp3 (M-M) |
101/100 |
br9* |
pro3 –casp8 → casp3 (M-M) |
br28 |
pro3 –casp9 → casp3 (M-M) |
10-3/100 |
|
|
br29 |
pro7 –casp8 → casp7 (M-M) |
100/10-1 |
br10* |
pro7 –casp8 → cleavage () |
br30 |
pro7 –casp9 → casp7 (M-M) |
10-5/10-3 |
|
|
PARP inactivation | ||||
br31 |
PARP -casp3 → cPARP (М-М) |
10-1 |
br11* |
PARP -casp3 → cPARP () |
br32 |
PARP –casp7 → cPARP (М-М) |
100/10-1 |
|
|
Inhibition of caspases-3, -7 and −9 | ||||
br33 |
casp3 + IAP → casp3:IAP (МA) |
100 |
br12* |
casp3 + IAP → inhibition (MA) |
br34 |
casp7 + IAP → casp7:IAP (МA) |
10-1 |
|
|
br35 |
casp9 + IAP → casp9:IAP (МA) |
10-3 |
|
|
br36 |
casp3:IAP → casp3 + IAP (МA) |
10-2 |
|
|
br37 |
casp7:IAP → casp7 + IAP (МA) |
10-4/10-3 |
|
|
br38 |
casp9:IAP → casp9 + IAP (МA) |
10-5/10-4 |
|
|
Production of the virtual variablexaa | ||||
br39 | → xaa (1 − xaa/Km367act + (1 − xaa) · (k36act · Ccasp3 + k36act · Ccasp6 + k7act · Ccasp7)) | 100 | br13* | → xaa () |
Prototypes of parameter notations in the original Bentele’s model are listed in Additional file 1: Table 1S. Abbreviations used in the table represent МA – mass action kinetics and M-M – Michaelis-Menten kinetics. The column with rates includes rate orders for the fast/reduced activation scenarios.